SECONDARY GENETIC ABBERATIONS AND THEIR EFFECT ON PROGNOSIS IN CORE BINDING FACTOR - ACUTE MYELOID LEUKEMIA (CBF-AML)

被引：0
|
作者：
Markova, J. [1 ]
Trnkova, Z. [1 ]
Maaloufova, J. [1 ]
Stary, J. [2 ]
Cetkovsky, P. [1 ]
Schwarz, J. [1 ]
机构：
[1] Inst Hematol & Blood Transfus, CR-12820 Prague 2, Czech Republic
[2] Fac Hosp Motol, Dept Pediat Hematol & Oncol, Prague 5, Czech Republic
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0501
引用
收藏
页码：203 / 203
页数：1
相关论文
共 50 条
  • [21] Response Kinetics and Factors Predicting Survival Among Patients with Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
    Boddu, Prajwal
    Gurguis, Christopher
    Cortes, Jorge E.
    Akosile, Mary
    Ravandi, Farhad
    Sanford, David
    Brandt, Mark
    Maduike, Rita
    Kadia, Tapan
    Kantarjian, Hagop M.
    Borthakur, Gautam
    BLOOD, 2017, 130
  • [22] Clonal Interference of Signaling Mutations Holds Prognostic Relevance in Core Binding Factor (CBF) Acute Myeloid Leukemia (AML)
    Itzykson, Raphael
    Duployez, Nicolas
    Fasan, Annette
    Marceau-Renaut, Alice
    Meggendorfer, Manja
    Jourdan, Eric
    Petit, Arnaud
    Lapillonne, Helene
    Micol, Jean-Baptiste
    Cornillet-Lefebvre, Pascale
    Ifrah, Norbert
    Leverger, Guy
    Dombret, Herve
    Boissel, Nicolas
    Haferlach, Torsten
    Preudhomme, Claude
    BLOOD, 2017, 130
  • [23] RNA Sequencing-Based Measurement of Fusion-Transcript for Minimal Residual Disease (MRD) Monitoring in Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)
    Kim, Taehyung
    Moon, Joon Ho
    Ahn, Jae-Sook
    Tyndel, Marc S.
    Lee, Seung-Shin
    Ahn, Seo-Yeon
    Jung, Sung-Hoon
    Yang, Deok-Hwan
    Lee, Je-Jung
    Choi, Seunghyun
    Lee, Ja-yeon
    Lee, Yoojin
    Sohn, Sang Kyun
    Zhang, Zhaolei
    Kim, Hyeoung-Joon
    Kim, Dennis Dong Hwan
    BLOOD, 2018, 132
  • [24] High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML)
    Libing Wang
    Lei Gao
    Sheng Xu
    Shenglan Gong
    Min Liu
    Huiying Qiu
    Xiaoqian Xu
    Xiong Ni
    Li Chen
    Shuqing Lu
    Jie Chen
    Xianmin Song
    Weiping Zhang
    Jianmin Yang
    Xiaoxia Hu
    Jianmin Wang
    Annals of Hematology, 2014, 93 : 1685 - 1694
  • [25] Characterization of Survival Outcomes and Clinical and Molecular Modulators in Adult Patients with Core-Binding Factor Acute Myeloid Leukemia (CBF-AML) Treated with Hidac Consolidation: An Alliance Legacy Study
    Hyak, Jonathan
    Nicolet, Deedra
    Kohlschmidt, Jessica
    Archer, Kellie J.
    Blachly, James S.
    Larkin, Karilyn T.
    Powell, Bayard L.
    Kolitz, Jonathan E.
    Baer, Maria R.
    Blum, William G.
    Uy, Geoffrey L.
    Stock, Wendy
    Stone, Richard M.
    Byrd, John C.
    Mrozek, Krzysztof
    Eisfeld, Ann-Kathrin
    Mims, Alice S.
    BLOOD, 2022, 140 : 1284 - 1285
  • [26] High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML)
    Wang, Libing
    Gao, Lei
    Xu, Sheng
    Gong, Shenglan
    Liu, Min
    Qiu, Huiying
    Xu, Xiaoqian
    Ni, Xiong
    Chen, Li
    Lu, Shuqing
    Chen, Jie
    Song, Xianmin
    Zhang, Weiping
    Yang, Jianmin
    Hu, Xiaoxia
    Wang, Jianmin
    ANNALS OF HEMATOLOGY, 2014, 93 (10) : 1685 - 1694
  • [27] Core Binding Factor Acute Myeloid Leukemia of the Elderly Treated with Conventional Chemotherapy : A Collaborative Study of the French CBF AML Intergroup
    Prebet, Thomas
    Boissel, Nicolas
    Recher, Christian
    Thomas, Xavier
    Delaunay, Jacques
    Cahn, Jean-Yves
    Pigneux, Arnaud
    Quesnel, Bruno
    Witz, Francis
    Thepot, Sylvain
    Ugo, Valerie
    Terre, Christine
    Tavernier, Emmanuelle
    Castaigne, Sylvie
    Guilhot, Francois
    Dombret, Herve
    Vey, Norbert
    BLOOD, 2008, 112 (11) : 206 - 207
  • [28] Prognosis factor study in acute myeloid leukemia (AML).
    Lacombe, F
    Marit, G
    Dumain, P
    Faberes, C
    Boiron, JM
    Belloc, F
    ConyMakhoul, P
    BilhouNabera, C
    Bernard, P
    Reiffers, J
    BLOOD, 1997, 90 (10) : 284 - 284
  • [29] Prevalence and Prognosis of Secondary Genetic Aberrations Among Patients With Core Binding Factor Acute Myeloid Leukemia: A Mitelman Database Analysis
    Ramirez, Renzo Martin Chapilliquen
    Pachas, Mariana Teresa de Jesus Corbacho
    Dongo, Richard Junior Zapata
    WORLD JOURNAL OF ONCOLOGY, 2023, 14 (06) : 488 - 498
  • [30] JAK2 V617F mutation screening in patients with chronic myeloproliferative disorders and core binding factor acute myeloid leukemias (CBF-AML)
    Markova, J.
    Michkova, P.
    Star, J.
    Schwarz, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 393 - 393
12345